Synapse - Juliet Barker

Results (335)

The Memorial Sloan-Kettering experience with allogeneic stem cell transplantation for T cell non-Hodgkins lymphomas

Meeting Abstract

Goldberg, J. D.; Chou, J.; Jakubowski, A. A.; Arcila, M. E.; Teruya-Feldstein, J.; Horwitz, S.; Barker, J. N.; Boulad, F.; Castro-Malaspina, H. R.; Hsu, K.; more...
Biology of Blood and Marrow Transplantation (2010)

Fulltext@MSK | Save

Adoptive immune cell therapy using third party T-cell donors in the treatment of EBV related diseases in immunodeficient recipients

Meeting Abstract

Prockop, S.; Doubrovina, E.; Boulad, F.; Kernan, N. A.; Kobos, R.; Scaradavou, A.; Small, T. N.; Khalaf, R.; Barker, J.; Koehne, G.; more...
Blood (2010)

Fulltext@MSK | Save

Vaccine response in recipients of HLA mismatched unrelated double unit cord blood transplantation (CBT)

Meeting Abstract

Small, T. N.; Iovino, C. S.; Abboud, M.; Lubin, M.; Papadopoulos, E.; Scaradavou, A.; Barker, J. N.
Blood (2010)

Fulltext@MSK | Save

A novel reduced intensity conditioning can induce a high incidence of sustained donor engraftment after double unit cord blood transplantation (CBT) without anti-thymocyte globulin

Meeting Abstract

Ponce, D. M.; Sauter, C.; Lubin, M.; Gonzales, A. M.; Heller, G.; Castro-Malaspina, H.; Giralt, S.; Kernan, N. A.; Papadopoulos, E. B.; Scaradavou, A.; more...
Blood (2010)

Fulltext@MSK | Save

Pertussis response to Tdap (8 mcg/dose of the Pertussis Toxoid (PT) in recipients of allogeneic hematopoietic stem cell transplants (Allo HSCT)

Meeting Abstract

Papadopoulos, E.; Iovino, C. S.; Knowles, M.; Barker, J.; Scaradavou, A.; Kernan, N. A.; Small, T. N.
Blood (2010)

Fulltext@MSK | Save

A phase I-II dose escalation trial of clofarabine plus melphalan and thiotepa followed by unmodified allogeneic stem cell transplant (SCT) for the treatment of high risk or advanced acute leukemia